Early Notification & Brand Change Metformin Tablets
As advised via Pharmac Tender announcement 31 May 2018 there is to be a change in the listing and future sole supply.
Click here to read the notification received from API 11 September 2018 advising of their stock situation. It explains why there is a change in listing date for the Metformin Tab 500 mg.
New early listing from 1 October 2018 (initially 1 December 2018)
Metformin-Apotex Tab 500 mg 1000 Pharmacode 2400995 Schedule price $8.63
New listing from 1 December 2018
Metformin-Apotex Tab 850 mg 500 Pharmacode 2401002 Schedule price $7.04
Metchek Tab 500 mg 1000 Pharmacode 2479613 Schedule price $9.59
Metformin Mylan Tab 850 mg 500 Pharmacode 2479265 Schedule price $7.82
Reference pricing will apply from 1 February 2019
HML (Hospital Supply Status) commences 1 February 2019 and CSS (Community Supply Status) commences 1 May 2019
As of the date of this notification ProPharma / PWR cannot accept Metchek & Metformin-Mylan for credit under any circumstances.
We would recommend you continue to purchase the incumbent and we will change automatically as existing stocks are exhausted.
Once again we need your support to ensure stock in the supply chain moves through, to effectively ensure no losses are incurred.
Together we can make this a seamless and painless transition.
We thank you in anticipation of your ongoing support.